Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide.
about
New viruses for cancer therapy: meeting clinical needsOncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsDevelopment of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsEngineered Viruses as Genome Editing DevicesHarnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinomaPeering below the diffraction limit: robust and specific sorting of viruses with flow cytometryModification of mammalian reoviruses for use as oncolytic agentsDevelopment of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In VivoTraceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivoTargeting of Magnetic Nanoparticle-coated Microbubbles to the Vascular Wall Empowers Site-specific Lentiviral Gene Delivery in vivoAll-in-one processing of heterogeneous human cell grafts for gene and cell therapy.Cell-specific multifunctional processing of heterogeneous cell systems in a single laser pulse treatmentSelective gene transfection of individual cells in vitro with plasmonic nanobubbles.Adenoviral vector immunity: its implications and circumvention strategies.Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerEngineering biodegradable and multifunctional peptide-based polymers for gene delivery.The influence of innate and pre-existing immunity on adenovirus therapyChemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirusChemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells.Integrin Targeted MR Imaging.Minimally invasive molecular delivery into the brain using optical modulation of vascular permeability.Adenovirus receptors and their implications in gene deliveryEnhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseAdenoviral delivery of the EMX2 gene suppresses growth in human gastric cancer.Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cellsSpecies differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirusThe challenge for gene therapy: innate immune response to adenovirusesEngineering biomaterial systems to enhance viral vector gene delivery.Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapyIncreasing the efficacy of oncolytic adenovirus vectorsUsing inositol as a biocompatible ligand for efficient transgene expression.Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity.Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus.Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers.Influence of method of systemic administration of adenovirus on virus-mediated toxicity: focus on mortality, virus distribution, and drug metabolism.Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapyTargeted Cancer Therapy with Tumor Necrosis Factor-Alpha.Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells.
P2860
Q24567699-61066E4F-2883-4E0A-BB19-0E11B34BF6EAQ26776553-172A8BE2-F80A-43AB-B753-CA88AF9479C0Q26782083-3F5D305D-0015-4FE9-B077-AACBD2FB24F5Q26785927-2CB296D1-5297-4407-B921-22636C520F2EQ27488744-6C21C08A-B3CE-4DE9-B105-3EAEC96FB3B2Q28119691-3BBD2652-7300-492D-8539-9F9FAAC45185Q28264900-16BCCA7A-3E71-4266-997F-BB627DFCF8B0Q28534124-BE125709-2E2A-4FD2-981B-1110506BDEB3Q28539158-A058E701-2A7D-42B5-94EF-0DC1009AE38BQ28818444-71C97DA5-DA4A-4C1B-B7BD-C33C91D1056AQ30387995-83EA6A99-BFF8-49A0-A5E0-A87E98EBF78FQ30445564-B1CA54A8-859D-4DBC-BF16-78225A0B7B6AQ30466731-CBB23A64-8BD8-4720-BAFF-B12146BA6A64Q33565630-16E18370-F42B-404D-A86F-E41E95184A2AQ33584756-162834D1-1ED7-4F80-A2D9-D5A6DB6BDF78Q33589634-5FAACA8C-FE88-49AD-8E25-D930C6FA400FQ33655401-DAD7B829-652D-4BE2-BED3-6C23646F81BEQ33690982-2C19B8EE-2DC2-4994-9832-0C83500BDC0AQ33862005-4CCD2BB6-AD1A-447B-BE2B-7E91EF2B591FQ33890945-DBD2AC31-6648-4E68-8910-64A29ECCE9EAQ33901944-5CA29830-641B-4719-B582-E45ED0BC585BQ33994011-8A8E8D61-EDD1-494D-AC84-D4BC93693963Q34069571-442C6C1A-5C0B-4D74-86E6-610C9E0F1E99Q34218552-051F92F9-AB3A-4FC5-BF43-C16AADCA0042Q34430506-21464E2C-FAD9-41BB-95D3-3E7A5D89E760Q34473365-851FD45D-AFB5-46AB-8C18-2087832961F5Q34975214-D3E31B6A-209B-461E-AA2B-27468F9F9B0EQ34975228-CF691261-CECF-42E7-8CFF-A101DAE495EAQ35144415-EEF7F01B-3ADB-4D22-9E7D-843A172D3F76Q35238254-2AA08B55-A580-432B-A837-7D51EC528724Q35261325-430C1C4D-63B0-411A-9059-389FB452FDBCQ35491335-C61F15A2-75B0-4393-A435-DF6AFC0E4722Q35624010-71D7F089-9819-4CDE-81A3-C8060597F0B3Q35666180-4BAD8E4A-1826-4628-81F2-13E95845D9F7Q35785494-8FE8AE5A-B8D9-4764-9E68-812AC3B48652Q35869766-E64B697B-B32A-4A1E-B9EF-03848E058C3BQ36395442-D1727145-41EB-4CFA-9BB4-9E03D972919AQ36395971-632011B8-8256-4A2C-A25D-74CD6929AB85Q37220415-3CFA0B2C-A936-48E6-8457-D36409FF4298Q37376339-108BEA33-C0B6-41E5-A702-668FAA3EE416
P2860
Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Modification of adenovirus gen ...... ic review and technical guide.
@ast
Modification of adenovirus gen ...... ic review and technical guide.
@en
Modification of adenovirus gen ...... ic review and technical guide.
@nl
type
label
Modification of adenovirus gen ...... ic review and technical guide.
@ast
Modification of adenovirus gen ...... ic review and technical guide.
@en
Modification of adenovirus gen ...... ic review and technical guide.
@nl
prefLabel
Modification of adenovirus gen ...... ic review and technical guide.
@ast
Modification of adenovirus gen ...... ic review and technical guide.
@en
Modification of adenovirus gen ...... ic review and technical guide.
@nl
P356
P1433
P1476
Modification of adenovirus gen ...... ic review and technical guide.
@en
P2093
Florian Kreppel
Stefan Kochanek
P356
10.1038/SJ.MT.6300321
P577
2007-10-02T00:00:00Z